A relatively new model is the MUP-uPA transgenic mouse line, which expresses transiently high amounts of urokinase plasminogen activator in hepatocytes, and develops both NASH pathology and extensive metabolic dysfunction when fed a HFD. This evidence concerns the gene PLAU and metabolic dysfunction-associated steatohepatitis.